FDA approved a new rizatriptan orally disintegrating film, Rizafilm.
FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.
Drug Discovery and Development Interview with Dr. Alex Feoktistov on new treatment options.
https://www.drugdiscoverytrends.com/a-neurologist-dishes-on-the-migraine-treatment-landscape/
You Might Also Enjoy...
FDA recently cleared Nerivio for preventive treatment of migraine
The prescription wearable neuromodulation device, Nerivio, was recently cleared by the FDA for preventive treatment of migraine.
Recently FDA approved nasal spray for acute migraine treatment is coming to market.
FDA has approved a new nasal spray for acute treatment of migraine in adults.
Adolescent Migraine: Q & A with Dr. Feoktistov and Migraine.com
A brief discussion about a balanced approach to migraine treatment that may include lifestyle modifications, medications, and the state-of-the-art approved neuromodulation devices that may help treat and prevent migraine attacks.
Advanced option in migraine management
Dr. Alex's interview with MassDevice medical network about novel options in migraine management: CGRP active drugs and non-invasive neuromodulation devices approved for migraine treatment.
Welcome to the series of Get Healthy 360 Headache Podcasts with Dr. Alex Feoktistov
This is the first episode of our three-part special on headaches with renowned headache specialist Alexander Feoktistov MD, PhD. Dr. Feoktistov discusses common causes of headaches, process of correct diagnosis, and types of headaches.